Table 8.
Distribution of vitamin D levels in different rs4588 and rs7041 genetic variants across the COVID-19 outcome on discharge in COVID-19 patients’ group (n = 140)
| Mortality of COVID-19 | χ2 | P-value | ||
|---|---|---|---|---|
| Survived (n = 126) |
Non survived (n = 14) |
|||
| Genotype (rs4588) | ||||
| CC | 84(66.7%) | 6(42.9%) | 3.1 | 0.07 |
| AA | 6(4.8%) | 0(0.0%) | 0.7 | 0.4 |
| CA | 36(28.6%) | 8(57.1%) | 4.7 | 0.03* |
| Genotype (rs7041) | ||||
| TT | 24(19.0%) | 0(0.0%) | 3.2 | 0.07 |
| GG | 50(39.7%) | 4(28.6%) | 0.6 | 0.4 |
| TG | 52(41.3%) | 10(71.4%) | 4.6 | 0.03* |
| Vitamin D Median (min -max) | 4.2(3.2–6.1) | 4.8(2–13) | U = 567 | 0.09 |
χ2: Chi-square test, the p-value for comparing the two studied groups. Data are expressed as the number and percentage of patients, *: Statistically significant at p ≤ 0.05